Portfolio Holdings Detail for ISIN IE00BDZVHG35
Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /var/www/liquidata/show_ticker_holding_ETFs.php on line 77
Stock Name / Fund iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Issuer Blackrock

ETF Ticker BTEE(USD) LSE
ETF Ticker BTEE.L(GBP) LSE

Holdings detail for BBIO

Stock Name	BridgeBio Pharma Inc
Ticker	BBIO(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US10806X1028
LEI	54930028YG89VTY2J114

Show aggregate BBIO holdings

News associated with BBIO

How The Parts Add Up: SCHK Headed For $35: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-09-15 07:18:20
BridgeBio Pharma (NASDAQ:BBIO) Price Target Raised to $70.00 at HC Wainwright: BridgeBio Pharma (NASDAQ:BBIO – Free Report) had its price target raised by HC Wainwright from $56.00 to $70.00 in a research report report published on Friday,Benzinga reports. The brokerage currently has a buy rating on the stock. A number of other analysts have also recently weighed in on BBIO. Wall Street Zen raised shares of […] - 2025-09-01 03:10:44
BridgeBio Pharma (NASDAQ:BBIO) CFO Sells $2,089,886.76 in Stock: BridgeBio Pharma, Inc. (NASDAQ:BBIO – Get Free Report) CFO Thomas Trimarchi sold 42,237 shares of the stock in a transaction on Thursday, August 21st. The shares were sold at an average price of $49.48, for a total value of $2,089,886.76. Following the sale, the chief financial officer owned 421,081 shares in the company, valued at […] - 2025-08-25 05:07:01
BridgeBio Pharma, Inc. (NASDAQ:BBIO) Shares Sold by Swiss National Bank: Swiss National Bank cut its holdings in BridgeBio Pharma, Inc. (NASDAQ:BBIO – Free Report) by 1.0% in the 1st quarter, according to its most recent 13F filing with the SEC. The fund owned 238,000 shares of the company’s stock after selling 2,300 shares during the period. Swiss National Bank’s holdings in BridgeBio Pharma were worth […] - 2025-08-17 05:54:57
Sum Up The Parts: JHSC Could Be Worth $46: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-08-15 09:39:16
Vanguard Group Inc. Cuts Stock Position in BridgeBio Pharma, Inc. (NASDAQ:BBIO): Vanguard Group Inc. lessened its position in BridgeBio Pharma, Inc. (NASDAQ:BBIO – Free Report) by 1.2% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 14,900,145 shares of the company’s stock after selling 177,770 shares during the quarter. Vanguard Group Inc. owned approximately 0.08% of […] - 2025-08-15 06:12:53
BridgeBio Pharma (NASDAQ:BBIO) Raised to “Hold” at Wall Street Zen: BridgeBio Pharma (NASDAQ:BBIO – Get Free Report) was upgraded by investment analysts at Wall Street Zen from a “sell” rating to a “hold” rating in a report issued on Saturday. BBIO has been the topic of several other research reports. Wells Fargo & Company lifted their price target on shares of BridgeBio Pharma from $67.00 […] - 2025-08-11 03:58:51
Brokerages Set BridgeBio Pharma, Inc. (NASDAQ:BBIO) PT at $61.50: Shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO – Get Free Report) have received an average recommendation of “Buy” from the sixteen brokerages that are presently covering the company, Marketbeat reports. Sixteen analysts have rated the stock with a buy recommendation. The average 1-year price target among brokerages that have issued a report on the stock in […] - 2025-07-30 04:24:53
BridgeBio Pharma (NASDAQ:BBIO) Coverage Initiated at Truist Financial: Equities researchers at Truist Financial began coverage on shares of BridgeBio Pharma (NASDAQ:BBIO – Get Free Report) in a report issued on Monday, MarketBeat.com reports. The brokerage set a “buy” rating and a $66.00 price target on the stock. Truist Financial’s price target would indicate a potential upside of 44.20% from the company’s current price. […] - 2025-07-23 05:10:52
BridgeBio Pharma (NASDAQ:BBIO) Coverage Initiated at Jefferies Financial Group: Equities research analysts at Jefferies Financial Group initiated coverage on shares of BridgeBio Pharma (NASDAQ:BBIO – Get Free Report) in a note issued to investors on Monday, Marketbeat reports. The brokerage set a “buy” rating and a $70.00 price target on the stock. Jefferies Financial Group’s price target points to a potential upside of 49.03% […] - 2025-07-16 02:50:48
BridgeBio Pharma (NASDAQ:BBIO) Price Target Raised to $68.00 at Piper Sandler: BridgeBio Pharma (NASDAQ:BBIO – Free Report) had its price objective boosted by Piper Sandler from $63.00 to $68.00 in a research note published on Monday,Benzinga reports. The firm currently has an overweight rating on the stock. Several other equities research analysts have also recently weighed in on BBIO. Bank of America increased their price objective […] - 2025-07-15 06:21:07
BridgeBio Pharma (NASDAQ:BBIO) Raised to “Outperform” at Oppenheimer: BridgeBio Pharma (NASDAQ:BBIO – Get Free Report) was upgraded by stock analysts at Oppenheimer from a “market perform” rating to an “outperform” rating in a note issued to investors on Wednesday, Marketbeat Ratings reports. The brokerage presently has a $60.00 price objective on the stock. Oppenheimer’s price target would suggest a potential upside of 29.67% […] - 2025-07-11 02:20:48
Principal Financial Group Inc. Has $39.70 Million Position in BridgeBio Pharma, Inc. (NASDAQ:BBIO): Principal Financial Group Inc. lifted its stake in BridgeBio Pharma, Inc. (NASDAQ:BBIO – Free Report) by 9.3% during the first quarter, HoldingsChannel reports. The fund owned 1,148,292 shares of the company’s stock after purchasing an additional 98,153 shares during the quarter. Principal Financial Group Inc.’s holdings in BridgeBio Pharma were worth $39,696,000 as of its […] - 2025-07-07 05:54:48
BridgeBio Pharma, Inc. (NASDAQ:BBIO) Major Shareholder Sells $154,000,000.00 in Stock: BridgeBio Pharma, Inc. (NASDAQ:BBIO – Get Free Report) major shareholder Global Investors Lp Viking sold 3,500,000 shares of the stock in a transaction on Friday, June 27th. The stock was sold at an average price of $44.00, for a total value of $154,000,000.00. Following the completion of the sale, the insider owned 18,555,375 shares in […] - 2025-07-03 06:00:52
BridgeBio Pharma (NASDAQ:BBIO) Stock Price Expected to Rise, Wells Fargo & Company Analyst Says: BridgeBio Pharma (NASDAQ:BBIO – Get Free Report) had its price objective hoisted by equities researchers at Wells Fargo & Company from $67.00 to $76.00 in a report issued on Monday,Benzinga reports. The firm presently has an “overweight” rating on the stock. Wells Fargo & Company‘s target price indicates a potential upside of 77.65% from the […] - 2025-07-02 02:32:50
BridgeBio Pharma, Inc. (NASDAQ:BBIO) Given Average Recommendation of “Moderate Buy” by Brokerages: Shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO – Get Free Report) have earned a consensus rating of “Moderate Buy” from the thirteen analysts that are currently covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a hold recommendation and twelve have given a buy recommendation to the company. The average 12-month […] - 2025-06-30 02:46:48
BridgeBio Pharma, Inc. (NASDAQ:BBIO) Director Frank Mccormick Sells 100,000 Shares: BridgeBio Pharma, Inc. (NASDAQ:BBIO – Get Free Report) Director Frank Mccormick sold 100,000 shares of BridgeBio Pharma stock in a transaction on Tuesday, June 24th. The shares were sold at an average price of $44.23, for a total value of $4,423,000.00. Following the completion of the transaction, the director now owns 879,979 shares in the […] - 2025-06-29 05:16:56
BridgeBio Pharma (NASDAQ:BBIO) Given New $54.00 Price Target at Bank of America: BridgeBio Pharma (NASDAQ:BBIO – Get Free Report) had its price objective raised by equities researchers at Bank of America from $50.00 to $54.00 in a research report issued on Wednesday,Benzinga reports. The firm presently has a “buy” rating on the stock. Bank of America‘s target price would suggest a potential upside of 19.68% from the […] - 2025-06-27 02:28:43
BridgeBio Pharma (NASDAQ:BBIO) Given New $56.00 Price Target at HC Wainwright: BridgeBio Pharma (NASDAQ:BBIO – Get Free Report) had its price target lifted by analysts at HC Wainwright from $53.00 to $56.00 in a research note issued to investors on Monday,Benzinga reports. The firm currently has a “buy” rating on the stock. HC Wainwright’s price objective suggests a potential upside of 39.69% from the company’s previous […] - 2025-06-11 02:44:48
California State Teachers Retirement System Raises Stock Position in BridgeBio Pharma, Inc. (NASDAQ:BBIO): California State Teachers Retirement System lifted its stake in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO – Free Report) by 6.8% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 115,655 shares of the company’s stock after buying an additional 7,388 shares during the quarter. […] - 2025-06-05 06:18:53
BridgeBio Pharma, Inc. (NASDAQ:BBIO) Shares Acquired by Mackenzie Financial Corp: Mackenzie Financial Corp increased its stake in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO – Free Report) by 6.6% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 9,505 shares of the company’s stock after purchasing an additional 592 shares during the […] - 2025-06-05 05:26:59
Better High-Yield Dividend Stock to Buy Now: Pfizer vs. Prologis: Investors looking for sources of passive income to fuel their retirement dreams face a dilemma. Should you chase high yields from slow-growing businesses or invest in lower-yield providers with more predictable cash flows? - 2025-06-05 04:34:00
Dimensional Fund Advisors LP Reduces Stock Holdings in BridgeBio Pharma, Inc. (NASDAQ:BBIO): Dimensional Fund Advisors LP cut its holdings in BridgeBio Pharma, Inc. (NASDAQ:BBIO – Free Report) by 1.7% during the 4th quarter, Holdings Channel reports. The fund owned 61,665 shares of the company’s stock after selling 1,036 shares during the period. Dimensional Fund Advisors LP’s holdings in BridgeBio Pharma were worth $1,692,000 as of its most […] - 2025-05-15 04:32:47
Analysts Set BridgeBio Pharma, Inc. (NASDAQ:BBIO) Target Price at $57.09: Shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the twelve ratings firms that are presently covering the firm, Marketbeat Ratings reports. One research analyst has rated the stock with a hold rating and eleven have issued a buy rating on the company. The […] - 2025-05-14 02:34:53
Envestnet Asset Management Inc. Reduces Position in BridgeBio Pharma, Inc. (NASDAQ:BBIO): Envestnet Asset Management Inc. reduced its holdings in BridgeBio Pharma, Inc. (NASDAQ:BBIO – Free Report) by 18.6% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 12,926 shares of the company’s stock after selling 2,949 shares during the period. Envestnet Asset Management Inc.’s holdings in BridgeBio Pharma were worth $355,000 at the end of […] - 2025-05-06 04:22:45
BridgeBio Pharma (NASDAQ:BBIO) Reaches New 1-Year High After Better-Than-Expected Earnings: BridgeBio Pharma, Inc. (NASDAQ:BBIO – Get Free Report) shares reached a new 52-week high during trading on Wednesday following a better than expected earnings announcement. The company traded as high as $39.54 and last traded at $38.48, with a volume of 2185851 shares. The stock had previously closed at $36.42. The company reported ($0.88) earnings […] - 2025-05-02 02:09:05
BridgeBio Pharma Target of Unusually High Options Trading (NASDAQ:BBIO): BridgeBio Pharma, Inc. (NASDAQ:BBIO – Get Free Report) saw some unusual options trading activity on Monday. Stock investors purchased 5,930 put options on the company. This is an increase of 67% compared to the typical volume of 3,542 put options. Wall Street Analysts Forecast Growth A number of equities research analysts have commented on the […] - 2025-04-30 04:24:51
BridgeBio Pharma, Inc. (NASDAQ:BBIO) Shares Acquired by Legal & General Group Plc: Legal & General Group Plc increased its position in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO – Free Report) by 2.8% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 134,038 shares of the company’s stock after acquiring an additional 3,706 shares […] - 2025-04-23 05:21:00
BridgeBio Pharma, Inc. (NASDAQ:BBIO) Shares Sold by Prudential Financial Inc.: Prudential Financial Inc. reduced its stake in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO – Free Report) by 24.4% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 10,429 shares of the company’s stock after selling 3,360 shares during the period. Prudential Financial Inc.’s holdings in BridgeBio […] - 2025-04-11 05:02:57
Vanguard Group Inc. Buys 879,059 Shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO): Vanguard Group Inc. raised its stake in BridgeBio Pharma, Inc. (NASDAQ:BBIO – Free Report) by 6.2% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 15,077,915 shares of the company’s stock after purchasing an additional 879,059 shares during the period. Vanguard […] - 2025-04-03 04:37:03

iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) BBIO holdings

Date	Number of BBIO Shares Held	Base Market Value of BBIO Shares	Local Market Value of BBIO Shares	Change in BBIO Shares Held	Change in BBIO Base Value	Current Price per BBIO Share Held	Previous Price per BBIO Share Held
2025-11-11 (Tuesday)	124,199	USD 8,269,169	USD 8,269,169	0	USD 468,230	USD 66.58	USD 62.81
2025-11-10 (Monday)	124,199	USD 7,800,939	USD 7,800,939	317	USD 145,031	USD 62.81	USD 61.8
2025-11-07 (Friday)	123,882	USD 7,655,908	USD 7,655,908	0	USD -115,210	USD 61.8	USD 62.73
2025-11-06 (Thursday)	123,882	USD 7,771,118	USD 7,771,118	317	USD 28,535	USD 62.73	USD 62.66
2025-11-05 (Wednesday)	123,565	USD 7,742,583	USD 7,742,583	0	USD 159,399	USD 62.66	USD 61.37
2025-11-04 (Tuesday)	123,565	USD 7,583,184	USD 7,583,184	319	USD -55,603	USD 61.37	USD 61.98
2025-11-03 (Monday)	123,246	USD 7,638,787	USD 7,638,787	0	USD -81,342	USD 61.98	USD 62.64
2025-10-31 (Friday)	123,246	USD 7,720,129	USD 7,720,129	0	USD -89,970	USD 62.64	USD 63.37
2025-10-30 (Thursday)	123,246	USD 7,810,099	USD 7,810,099	1,595	USD -294,291	USD 63.37	USD 66.62
2025-10-29 (Wednesday)	121,651	USD 8,104,390	USD 8,104,390	1,210	USD 335,945	USD 66.62	USD 64.5
2025-10-28 (Tuesday)	120,441	USD 7,768,445	USD 7,768,445	0	USD 113,215	USD 64.5	USD 63.56
2025-10-27 (Monday)	120,441	USD 7,655,230	USD 7,655,230	0	USD 1,120,101	USD 63.56	USD 54.26

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of BBIO by Blackrock for IE00BDZVHG35

Show aggregate share trades of BBIO

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-11-10 BUY 317 63.230 62.060 62.177 USD 19,710 37.44
2025-11-06 BUY 317 64.440 62.150 62.379 USD 19,774 37.17
2025-11-04 BUY 319 61.905 60.230 60.397 USD 19,267 36.90
2025-10-30 BUY 1,595 67.750 62.705 63.210 USD 100,819 36.47
2025-10-29 BUY 1,210 66.620 69.480 69.194 USD 83,725 36.30
2025-10-22 SELL -1,268 53.240 54.570 54.437 USD -69,026 35.68 Loss of -23,789 on sale
2025-10-20 BUY 634 56.255 56.300 56.295 USD 35,691 35.45
2025-10-17 BUY 1,584 54.920 55.485 55.429 USD 87,799 35.33
2025-10-15 BUY 2,528 56.630 57.490 57.404 USD 145,117 35.21
2025-10-03 BUY 2,198 52.860 53.783 53.691 USD 118,012 34.97
2025-10-02 BUY 314 53.280 53.745 53.698 USD 16,861 34.86
2025-09-30 BUY 628 51.940 52.363 52.321 USD 32,857 34.64
2025-09-26 BUY 628 50.050 50.100 50.095 USD 31,460 34.44
2025-09-25 BUY 628 49.000 50.250 50.125 USD 31,479 34.35
2025-09-18 BUY 327 53.330 53.380 53.375 USD 17,454 34.23
2025-09-17 BUY 984 51.180 52.720 52.566 USD 51,725 34.13
2025-07-17 SELL -656 46.740 47.480 47.406 USD -31,098 33.78 Loss of -8,940 on sale
2025-07-16 BUY 1,102 47.100 47.660 47.604 USD 52,460 33.69
2025-07-11 SELL -2,600 46.470 46.760 46.731 USD -121,501 33.43 Loss of -34,593 on sale
2025-07-02 BUY 17,875 42.830 43.155 43.122 USD 770,815 33.12
2025-06-25 BUY 650 44.380 45.180 45.100 USD 29,315 32.80
2025-06-20 BUY 2,609 41.730 41.935 41.915 USD 109,355 32.59
2025-06-11 BUY 632 39.050 40.380 40.247 USD 25,436 32.20
2025-06-10 BUY 632 40.090 40.400 40.369 USD 25,513 32.14
2025-06-04 SELL -316 38.020 39.110 39.001 USD -12,324 31.94 Loss of -2,231 on sale
2025-04-23 BUY 316 35.230 36.110 36.022 USD 11,383 30.99
2025-04-10 SELL -2,528 32.310 32.880 32.823 USD -82,977 30.71 Loss of -5,353 on sale
2025-04-08 SELL -316 30.140 32.770 32.507 USD -10,272 30.69 Loss of -575 on sale
2025-04-07 SELL -316 30.670 32.290 32.128 USD -10,152 30.69 Loss of -455 on sale
2025-04-04 SELL -1,580 31.370 33.885 33.633 USD -53,141 30.68 Loss of -4,668 on sale
2025-04-01 BUY 2,751 33.020 34.500 34.352 USD 94,502 30.60
2025-03-31 SELL -933 34.570 35.370 35.290 USD -32,926 30.56 Loss of -4,417 on sale
2025-03-21 BUY 4,628 34.770 35.090 35.058 USD 162,248 30.12
2025-03-14 SELL -4,736 32.970 33.450 33.402 USD -158,192 29.91 Loss of -16,554 on sale
2025-03-07 SELL -592 31.570 32.640 32.533 USD -19,260 29.74 Loss of -1,651 on sale
2025-03-04 SELL -296 33.540 33.920 33.882 USD -10,029 29.56 Loss of -1,279 on sale
2025-02-25 BUY 592 34.350 35.460 35.349 USD 20,927 29.18
2025-02-19 SELL -296 36.290 36.590 36.560 USD -10,822 28.63 Loss of -2,346 on sale
2025-02-13 BUY 888 31.560 32.640 32.532 USD 28,888 28.19
2025-02-12 BUY 296 31.950 32.010 32.004 USD 9,473 28.11
2025-02-11 BUY 1,184 31.120 32.106 32.007 USD 37,897 28.05
2024-12-30 SELL -10,569 27.320 27.990 27.923 USD -295,118 25.54 Loss of -25,237 on sale
2024-11-18 SELL -4,875 22.350 24.250 24.060 USD -117,293 24.88 Profit of 4,004 on sale
2024-11-08 SELL -325 27.090 27.270 27.252 USD -8,857 24.74 Loss of -816 on sale
2024-10-30 BUY 1,152 23.790 24.675 24.586 USD 28,324 24.50
2024-10-21 SELL -322 25.160 26.100 26.006 USD -8,374 0.00 Loss of -8,374 on sale
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-11-10	BUY	317	63.230	62.060	62.177	USD 19,710	37.44
2025-11-06	BUY	317	64.440	62.150	62.379	USD 19,774	37.17
2025-11-04	BUY	319	61.905	60.230	60.397	USD 19,267	36.90
2025-10-30	BUY	1,595	67.750	62.705	63.210	USD 100,819	36.47
2025-10-29	BUY	1,210	66.620	69.480	69.194	USD 83,725	36.30
2025-10-22	SELL	-1,268	53.240	54.570	54.437	USD -69,026	35.68 Loss of -23,789 on sale
2025-10-20	BUY	634	56.255	56.300	56.295	USD 35,691	35.45
2025-10-17	BUY	1,584	54.920	55.485	55.429	USD 87,799	35.33
2025-10-15	BUY	2,528	56.630	57.490	57.404	USD 145,117	35.21
2025-10-03	BUY	2,198	52.860	53.783	53.691	USD 118,012	34.97
2025-10-02	BUY	314	53.280	53.745	53.698	USD 16,861	34.86
2025-09-30	BUY	628	51.940	52.363	52.321	USD 32,857	34.64
2025-09-26	BUY	628	50.050	50.100	50.095	USD 31,460	34.44
2025-09-25	BUY	628	49.000	50.250	50.125	USD 31,479	34.35
2025-09-18	BUY	327	53.330	53.380	53.375	USD 17,454	34.23
2025-09-17	BUY	984	51.180	52.720	52.566	USD 51,725	34.13
2025-07-17	SELL	-656	46.740	47.480	47.406	USD -31,098	33.78 Loss of -8,940 on sale
2025-07-16	BUY	1,102	47.100	47.660	47.604	USD 52,460	33.69
2025-07-11	SELL	-2,600	46.470	46.760	46.731	USD -121,501	33.43 Loss of -34,593 on sale
2025-07-02	BUY	17,875	42.830	43.155	43.122	USD 770,815	33.12
2025-06-25	BUY	650	44.380	45.180	45.100	USD 29,315	32.80
2025-06-20	BUY	2,609	41.730	41.935	41.915	USD 109,355	32.59
2025-06-11	BUY	632	39.050	40.380	40.247	USD 25,436	32.20
2025-06-10	BUY	632	40.090	40.400	40.369	USD 25,513	32.14
2025-06-04	SELL	-316	38.020	39.110	39.001	USD -12,324	31.94 Loss of -2,231 on sale
2025-04-23	BUY	316	35.230	36.110	36.022	USD 11,383	30.99
2025-04-10	SELL	-2,528	32.310	32.880	32.823	USD -82,977	30.71 Loss of -5,353 on sale
2025-04-08	SELL	-316	30.140	32.770	32.507	USD -10,272	30.69 Loss of -575 on sale
2025-04-07	SELL	-316	30.670	32.290	32.128	USD -10,152	30.69 Loss of -455 on sale
2025-04-04	SELL	-1,580	31.370	33.885	33.633	USD -53,141	30.68 Loss of -4,668 on sale
2025-04-01	BUY	2,751	33.020	34.500	34.352	USD 94,502	30.60
2025-03-31	SELL	-933	34.570	35.370	35.290	USD -32,926	30.56 Loss of -4,417 on sale
2025-03-21	BUY	4,628	34.770	35.090	35.058	USD 162,248	30.12
2025-03-14	SELL	-4,736	32.970	33.450	33.402	USD -158,192	29.91 Loss of -16,554 on sale
2025-03-07	SELL	-592	31.570	32.640	32.533	USD -19,260	29.74 Loss of -1,651 on sale
2025-03-04	SELL	-296	33.540	33.920	33.882	USD -10,029	29.56 Loss of -1,279 on sale
2025-02-25	BUY	592	34.350	35.460	35.349	USD 20,927	29.18
2025-02-19	SELL	-296	36.290	36.590	36.560	USD -10,822	28.63 Loss of -2,346 on sale
2025-02-13	BUY	888	31.560	32.640	32.532	USD 28,888	28.19
2025-02-12	BUY	296	31.950	32.010	32.004	USD 9,473	28.11
2025-02-11	BUY	1,184	31.120	32.106	32.007	USD 37,897	28.05
2024-12-30	SELL	-10,569	27.320	27.990	27.923	USD -295,118	25.54 Loss of -25,237 on sale
2024-11-18	SELL	-4,875	22.350	24.250	24.060	USD -117,293	24.88 Profit of 4,004 on sale
2024-11-08	SELL	-325	27.090	27.270	27.252	USD -8,857	24.74 Loss of -816 on sale
2024-10-30	BUY	1,152	23.790	24.675	24.586	USD 28,324	24.50
2024-10-21	SELL	-322	25.160	26.100	26.006	USD -8,374	0.00 Loss of -8,374 on sale

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of BBIO

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	356,095	7,744	678,155	52.5%
2025-09-18	261,504	130	637,846	41.0%
2025-09-17	334,772	5	480,570	69.7%
2025-09-16	1,357,453	18,509	1,506,011	90.1%
2025-09-15	368,036	160	570,028	64.6%
2025-09-12	529,781	105	881,477	60.1%
2025-09-11	223,479	0	539,518	41.4%
2025-09-10	442,583	5	754,800	58.6%
2025-09-09	595,671	419	896,066	66.5%
2025-09-08	594,220	6,754	924,644	64.3%
2025-09-05	738,704	33,511	1,278,649	57.8%
2025-09-04	401,295	28,014	663,393	60.5%
2025-09-03	560,609	20,629	1,223,397	45.8%
2025-09-02	463,657	41,791	1,121,269	41.4%
2025-08-29	1,323,234	439,747	1,802,271	73.4%
2025-08-28	760,162	6,350	1,209,351	62.9%
2025-08-27	848,645	11,034	1,399,824	60.6%
2025-08-26	320,263	175	800,509	40.0%
2025-08-25	255,972	558	695,156	36.8%
2025-08-22	216,244	11,104	516,387	41.9%
2025-08-21	150,233	0	456,534	32.9%
2025-08-20	351,986	1,187	776,881	45.3%
2025-08-19	262,242	1,055	685,167	38.3%
2025-08-18	732,294	233,084	1,316,992	55.6%
2025-08-15	300,290	8,510	664,747	45.2%
2025-08-14	352,300	0	731,290	48.2%
2025-08-13	621,184	1,051	969,792	64.1%
2025-08-12	492,728	42,100	791,918	62.2%
2025-08-11	379,968	3,205	763,582	49.8%
2025-08-08	467,277	204	775,461	60.3%
2025-08-07	571,545	7,095	1,074,645	53.2%
2025-08-06	3,823,109	52,426	5,661,913	67.5%
2025-08-05	1,384,632	211	1,958,937	70.7%
2025-08-04	359,961	0	855,643	42.1%
2025-08-01	377,577	0	796,892	47.4%
2025-07-31	363,917	889	946,803	38.4%
2025-07-30	316,215	797	675,929	46.8%
2025-07-29	135,195	2,991	402,970	33.5%
2025-07-28	224,253	300	807,076	27.8%
2025-07-25	236,252	0	539,153	43.8%
2025-07-24	211,044	108	664,611	31.8%
2025-07-23	240,010	1,150	906,176	26.5%
2025-07-22	418,821	1,614	778,685	53.8%
2025-07-21	370,152	50	801,285	46.2%
2025-07-18	403,386	312	850,692	47.4%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.

Stock Name / Fund	iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Issuer	Blackrock
ETF Ticker	BTEE(USD) LSE
ETF Ticker	BTEE.L(GBP) LSE